
Nancy J. Leith
Examiner (ID: 12198, Phone: (313)446-4874 , Office: P/1636 )
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1636, 1811, 1815, 1941, 1805 |
| Total Applications | 1445 |
| Issued Applications | 999 |
| Pending Applications | 194 |
| Abandoned Applications | 284 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15360795
[patent_doc_number] => 20200016162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => INHIBITORS OF HUMAN EZH2, AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/453501
[patent_app_country] => US
[patent_app_date] => 2019-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43346
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16453501
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/453501 | INHIBITORS OF HUMAN EZH2, AND METHODS OF USE THEREOF | Jun 25, 2019 | Abandoned |
Array
(
[id] => 17236892
[patent_doc_number] => 11180764
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-23
[patent_title] => Univariant extrinsic initiator control system for microbes and an in vitro assembly of large recombinant DNA molecules from multiple components
[patent_app_type] => utility
[patent_app_number] => 16/447418
[patent_app_country] => US
[patent_app_date] => 2019-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 70
[patent_no_of_words] => 21842
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16447418
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/447418 | Univariant extrinsic initiator control system for microbes and an in vitro assembly of large recombinant DNA molecules from multiple components | Jun 19, 2019 | Issued |
Array
(
[id] => 15436187
[patent_doc_number] => 20200032277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
[patent_app_type] => utility
[patent_app_number] => 16/445150
[patent_app_country] => US
[patent_app_date] => 2019-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52045
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16445150
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/445150 | CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION | Jun 17, 2019 | Abandoned |
Array
(
[id] => 15436189
[patent_doc_number] => 20200032278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
[patent_app_type] => utility
[patent_app_number] => 16/445156
[patent_app_country] => US
[patent_app_date] => 2019-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51532
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16445156
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/445156 | CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION | Jun 17, 2019 | Abandoned |
Array
(
[id] => 20108550
[patent_doc_number] => 12359259
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-15
[patent_title] => Biomarkers for predicting prostate cancer progression
[patent_app_type] => utility
[patent_app_number] => 16/972984
[patent_app_country] => US
[patent_app_date] => 2019-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 59
[patent_no_of_words] => 8803
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16972984
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/972984 | Biomarkers for predicting prostate cancer progression | Jun 9, 2019 | Issued |
Array
(
[id] => 15263229
[patent_doc_number] => 20190380348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => COMPOSITIONS AND METHODS FOR THE IMPROVED PRODUCTION AND DELIVERY OF RNA BY EFFICIENT TRANSCRIPTION TERMINATION
[patent_app_type] => utility
[patent_app_number] => 16/434854
[patent_app_country] => US
[patent_app_date] => 2019-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26934
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16434854
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/434854 | Compositions and methods for the improved production and delivery of RNA by efficient transcription termination | Jun 6, 2019 | Issued |
Array
(
[id] => 16878265
[patent_doc_number] => 11028401
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-08
[patent_title] => Manipulation of genes involved in signal transduction to control fungal morphology during fermentation and production
[patent_app_type] => utility
[patent_app_number] => 16/433624
[patent_app_country] => US
[patent_app_date] => 2019-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 24
[patent_no_of_words] => 61393
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16433624
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/433624 | Manipulation of genes involved in signal transduction to control fungal morphology during fermentation and production | Jun 5, 2019 | Issued |
Array
(
[id] => 16964182
[patent_doc_number] => 20210215681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => METHOD FOR DETECTION OF UNSTABLE CELL-FREE DNA AND DEVICE USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/058267
[patent_app_country] => US
[patent_app_date] => 2019-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15277
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17058267
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/058267 | METHOD FOR DETECTION OF UNSTABLE CELL-FREE DNA AND DEVICE USING SAME | May 29, 2019 | Issued |
Array
(
[id] => 15268085
[patent_doc_number] => 20190382776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => In vitro DNA SCRaMbLE
[patent_app_type] => utility
[patent_app_number] => 16/418163
[patent_app_country] => US
[patent_app_date] => 2019-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10557
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16418163
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/418163 | In vitro DNA SCRaMbLE | May 20, 2019 | Issued |
Array
(
[id] => 17274757
[patent_doc_number] => 20210380955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => METHODS OF EDITING SINGLE NUCLEOTIDE POLYMORPHISM USING PROGRAMMABLE BASE EDITOR SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 17/054324
[patent_app_country] => US
[patent_app_date] => 2019-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69722
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17054324
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/054324 | METHODS OF EDITING SINGLE NUCLEOTIDE POLYMORPHISM USING PROGRAMMABLE BASE EDITOR SYSTEMS | May 10, 2019 | Pending |
Array
(
[id] => 14930477
[patent_doc_number] => 20190300876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => EXPRESSION VECTOR PRODUCTION AND HIGH-THROUGHPUT CELL SCREENING
[patent_app_type] => utility
[patent_app_number] => 16/407560
[patent_app_country] => US
[patent_app_date] => 2019-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21214
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16407560
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/407560 | Expression vector production and high-throughput cell screening | May 8, 2019 | Issued |
Array
(
[id] => 20239533
[patent_doc_number] => 12419836
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-23
[patent_title] => Extracellular vesicles derived from recombinant microorganism including polynucleotide encoding target protein and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/052319
[patent_app_country] => US
[patent_app_date] => 2019-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 17
[patent_no_of_words] => 2300
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17052319
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/052319 | Extracellular vesicles derived from recombinant microorganism including polynucleotide encoding target protein and use thereof | May 2, 2019 | Issued |
Array
(
[id] => 14747453
[patent_doc_number] => 20190256900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => NOVEL CRISPR ENZYMES AND SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 16/400026
[patent_app_country] => US
[patent_app_date] => 2019-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 207472
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16400026
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/400026 | Crispr enzymes and systems | Apr 29, 2019 | Issued |
Array
(
[id] => 15785383
[patent_doc_number] => 10626402
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-21
[patent_title] => Nuclease-mediated DNA assembly
[patent_app_type] => utility
[patent_app_number] => 16/296003
[patent_app_country] => US
[patent_app_date] => 2019-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 27752
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16296003
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/296003 | Nuclease-mediated DNA assembly | Mar 6, 2019 | Issued |
Array
(
[id] => 14501991
[patent_doc_number] => 20190194650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => METHODS FOR GENERATING BARCODED COMBINATORIAL LIBRARIES
[patent_app_type] => utility
[patent_app_number] => 16/295393
[patent_app_country] => US
[patent_app_date] => 2019-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51871
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 239
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16295393
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/295393 | Methods for generating barcoded combinatorial libraries | Mar 6, 2019 | Issued |
Array
(
[id] => 14747419
[patent_doc_number] => 20190256883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => METHOD FOR PRODUCING GLYCOPROTEIN HAVING MANNOSE RESIDUE AS NON-REDUCING END OF SUGAR CHAIN
[patent_app_type] => utility
[patent_app_number] => 16/292952
[patent_app_country] => US
[patent_app_date] => 2019-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8205
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16292952
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/292952 | Method for producing glycoprotein having mannose residue as non-reducing end of sugar chain | Mar 4, 2019 | Issued |
Array
(
[id] => 18526484
[patent_doc_number] => 11713472
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-01
[patent_title] => Genome editing in Archaea
[patent_app_type] => utility
[patent_app_number] => 16/291479
[patent_app_country] => US
[patent_app_date] => 2019-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 18172
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16291479
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/291479 | Genome editing in Archaea | Mar 3, 2019 | Issued |
Array
(
[id] => 19311836
[patent_doc_number] => 12037639
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-16
[patent_title] => CRISPR effector system based diagnostics
[patent_app_type] => utility
[patent_app_number] => 16/285128
[patent_app_country] => US
[patent_app_date] => 2019-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 224
[patent_no_of_words] => 73400
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16285128
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/285128 | CRISPR effector system based diagnostics | Feb 24, 2019 | Issued |
Array
(
[id] => 14406923
[patent_doc_number] => 20190169305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => RECOMBINANT OBLIGATE ANAEROBIC GRAM-POSITIVE BACTERIA
[patent_app_type] => utility
[patent_app_number] => 16/279627
[patent_app_country] => US
[patent_app_date] => 2019-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17582
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16279627
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/279627 | Recombinant obligate anaerobic Gram-positive bacteria | Feb 18, 2019 | Issued |
Array
(
[id] => 14960755
[patent_doc_number] => 20190307855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN
[patent_app_type] => utility
[patent_app_number] => 16/276156
[patent_app_country] => US
[patent_app_date] => 2019-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51926
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16276156
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/276156 | Fibronectin based scaffold domain proteins that bind to myostatin | Feb 13, 2019 | Issued |